- JP-listed companies
- KYORIN Pharmaceutical Co., Ltd.
KYORIN Pharmaceutical Co., Ltd.JP:4569
Market cap
¥97.3B
P/E ratio
18.3x
| Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | |
| Profit (loss) before income taxes | 18,603 | 18,312 | 17,561 | 18,815 | 9,716 | 9,061 | 9,359 | 8,255 | 8,352 | 5,216 | 6,906 | 7,019 |
| Depreciation | 2,738 | 3,153 | 3,053 | 3,730 | 3,619 | 3,644 | 2,940 | 3,221 | 3,564 | 3,714 | 3,840 | 4,290 |
| Impairment losses | - | - | 2,232 | - | - | - | - | - | - | - | 257 | - |
| Increase (decrease) in allowance for doubtful accounts | -302 | - | 10 | -11 | -67 | -16 | -1 | -5 | -3 | -3 | -6 | 5 |
| Increase (decrease) in provision for bonuses | 211 | -39 | -21 | -35 | -561 | -293 | -139 | 94 | -125 | 83 | -121 | 16 |
| Increase (decrease) in provision for share awards | - | - | - | - | - | - | - | - | -36 | 343 | 122 | -466 |
| Decrease (increase) in retirement benefit asset | - | - | -843 | -1,172 | -1,326 | 586 | 599 | 199 | 186 | 127 | 201 | 279 |
| Increase (decrease) in retirement benefit liability | - | 134 | -382 | 19 | 21 | 61 | -139 | -106 | -11 | 48 | 66 | 18 |
| Share of loss (profit) of entities accounted for using equity method | -39 | -22 | 7 | 24 | -23 | -28 | -36 | -19 | -49 | -25 | - | 12 |
| Interest and dividend income | -308 | -276 | -279 | -313 | -374 | -398 | -415 | -428 | -420 | -411 | -465 | -501 |
| Interest expenses | 38 | 11 | 6 | 17 | 29 | 24 | 64 | 75 | 68 | 66 | 66 | 66 |
| Loss (gain) on sale and retirement of non-current assets | 98 | 14 | -4,305 | -1,467 | 135 | 51 | 107 | 24 | -342 | 32 | 15 | 90 |
| Loss (gain) on sale of investment securities | -25 | -64 | - | -47 | -3 | - | -28 | -104 | -488 | - | -683 | -993 |
| Loss (gain) on valuation of investment securities | - | 18 | 2 | - | - | - | - | - | - | 320 | 9 | - |
| Loss (gain) on liquidation of subsidiaries | - | - | - | - | - | - | - | - | - | - | - | -410 |
| Gain on insurance claims | - | - | - | - | - | - | - | - | - | - | -881 | - |
| Compensation income for damage | - | - | - | - | - | - | - | - | - | - | -401 | - |
| Loss on liquidation of subsidiaries and associates | - | - | - | - | - | - | - | - | - | - | 605 | - |
| Premium allowance of retirement-OpeCF | - | - | - | - | - | - | - | - | - | - | - | 869 |
| Loss on disaster | - | - | - | - | - | - | - | - | - | - | - | 27 |
| Decrease (increase) in trade receivables | -1,480 | 2,445 | -2,877 | -1,288 | 2,102 | -1,842 | -4,773 | 5,185 | 7,001 | -1,226 | -5,621 | -439 |
| Decrease (increase) in inventories | 800 | -1,761 | -4,230 | -1,736 | 3,286 | 901 | -2,112 | -7,863 | -5,284 | -3,633 | -5,809 | -5,444 |
| Increase (decrease) in trade payables | -486 | 2,499 | 202 | 532 | -634 | -834 | 1,175 | -1,664 | -2,791 | 3,910 | 2,866 | 502 |
| Increase (decrease) in accrued consumption taxes | -144 | 9 | 1,117 | -1,446 | 945 | -912 | 349 | -101 | 195 | -35 | 219 | -183 |
| Other, net | -2,956 | 637 | -503 | -2,978 | 2,935 | 1,889 | -3,309 | 2,129 | -2,011 | -1,287 | -973 | -62 |
| Subtotal | 15,865 | 25,099 | 10,748 | 15,338 | 19,804 | 11,729 | 3,459 | 8,892 | 6,728 | 7,240 | 216 | 4,695 |
| Interest and dividends received | 323 | 294 | 289 | 320 | 381 | 405 | 422 | 436 | 428 | 420 | 473 | 501 |
| Interest paid | -21 | -11 | -6 | -17 | -29 | -24 | -64 | -75 | -68 | -66 | -66 | -66 |
| Proceeds from insurance income | - | - | - | - | - | - | - | - | - | - | 3,050 | - |
| Compensation income for damage received | - | - | - | - | - | - | - | - | - | - | 401 | - |
| Payments for voluntary early retirement-related expenses | - | - | - | - | - | - | - | - | - | - | - | -604 |
| Income taxes paid | -4,623 | -6,089 | -4,640 | -4,504 | -3,769 | -1,655 | -3,476 | -1,513 | -1,899 | -1,248 | -2,065 | -2,975 |
| Net cash provided by (used in) operating activities | 11,544 | 19,293 | 6,391 | 11,137 | 16,386 | 10,456 | 340 | 7,739 | 5,189 | 6,346 | 2,008 | 1,549 |
| Payments into time deposits | -1,328 | -865 | -777 | -622 | -1,443 | -768 | -622 | -954 | -622 | -622 | -622 | -910 |
| Proceeds from withdrawal of time deposits | 1,139 | 980 | 622 | 1,358 | 1,079 | 722 | 659 | 622 | 1,020 | 946 | 810 | 1,511 |
| Purchase of property, plant and equipment | -5,972 | -2,622 | -5,383 | -6,812 | -2,208 | -3,387 | -2,170 | -2,624 | -4,067 | -2,444 | -6,330 | -5,778 |
| Proceeds from sale of property, plant and equipment | - | 415 | 4,756 | 2,066 | 89 | 91 | 23 | 26 | 368 | - | 100 | - |
| Purchase of intangible assets | -344 | -473 | -472 | -530 | -437 | -486 | -2,199 | -593 | -1,057 | -246 | -3,075 | -468 |
| Purchase of investment securities | -3,501 | -4,509 | -6,905 | -8,008 | -16,600 | -7,099 | -620 | -100 | -1,407 | -3,407 | -100 | - |
| Proceeds from sale and redemption of investment securities | 6,853 | 7,829 | 4,413 | 8,301 | 6,403 | 5,000 | 19,997 | 804 | 1,641 | 3,400 | 3,193 | 2,044 |
| Proceeds from liquidation of subsidiaries | - | - | - | - | - | - | - | - | - | - | - | 921 |
| Other, net | -441 | 161 | -320 | -202 | -26 | -146 | -129 | -123 | -134 | -185 | -251 | -509 |
| Net cash provided by (used in) investing activities | -7,187 | -2,477 | -1,364 | 650 | -13,142 | -6,038 | 14,939 | -2,943 | -4,259 | -2,560 | -6,275 | -3,187 |
| Repayments of finance lease liabilities | -70 | -112 | -99 | -99 | -116 | -104 | -104 | -118 | -142 | -143 | -147 | -133 |
| Repayments of long-term borrowings | -386 | -343 | -308 | -764 | -1,153 | -1,297 | -1,582 | -832 | -428 | -200 | -200 | -200 |
| Net decrease (increase) in treasury shares | -2 | -1 | -2,186 | -458 | -445 | 524 | -40,839 | - | - | - | - | - |
| Dividends paid | -3,357 | -3,736 | -4,626 | -3,876 | -4,322 | -4,325 | -5,068 | -4,346 | -4,347 | -3,767 | -3,015 | -3,013 |
| Net cash provided by (used in) financing activities | -5,132 | -3,704 | -5,233 | -2,245 | -5,721 | -3,735 | -27,315 | -5,117 | -4,918 | -4,112 | -3,363 | -3,347 |
| Effect of exchange rate change on cash and cash equivalents | 108 | 173 | 105 | -226 | -65 | -210 | -22 | -22 | -43 | 139 | 241 | 87 |
| Net increase (decrease) in cash and cash equivalents | -667 | 13,285 | -100 | 9,315 | -2,543 | 471 | -12,057 | -343 | -4,033 | -186 | -7,388 | -4,897 |
| Decrease in cash and cash equivalents resulting from exclusion of subsidiaries from consolidation | - | - | - | - | - | - | - | -61 | - | - | -84 | -32 |